As shown in Supplementary Figure 7, group 1 curve crossed group 2 curve from 30 to 60 months, which means the combination of SLC2A1 and SLC2A2 might not be able to discriminate prognosis of HCC patients. The gene discussed is SLC2A1; the disease is hepatocellular carcinoma.